References
1. Panés J, Bouzas R, Chaparro M, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease: Systematic review: cross-sectional imaging in Crohn’s disease. Aliment Pharmacol Ther 2011;34(2):125-45.
2. Horsthuis K, Bipat S, Bennink R, et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008; 247:64–79.
3. Ripollés T, Martínez MJ, Paredes JM, et al. Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 2009;253 (1):241–8.
4. Medellín A, Merrill C, Wilson SR. Role of contrast-enhanced ultrasound in evaluation of the bowell. Abdom Radiol 2018; 43:918-933.
5. Pecere S, Holleran G, Ainora ME, et al. Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD). Digestive and Liver Disease 2018; 50: 761-767.
6. Calabrese E, Maaser C, Zorzi F, et al. Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts. Inflamm Bowel Dis 2016;22(5):1168-83.
7. Sasaki T, Kunisaki R, Kinoshita H, et al. Doppler ultrasound findings correlate with tissue vascularity and inflammation in surgical pathology specimens from patients with small intestinal Crohn's disease. BMC Res Notes 2014;7:363.
8. Migaleddu V, Scanu AM, Quaia E, et al. Contrast enhanced ultrasonographic evaluation of inflammatory activity in Crohn’s disease. Gastroenterology 2009;137 (1):43–52.
9. De Franco A, Di Veronica A, Armuzzi A, et al. Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity. Radiology 2012;262(2):680-8.
10. Ripollés T, Poza J, Suarez Ferrer C, et al. Evaluation of Crohn's Disease Activity: Development of an Ultrasound Score in a Multicenter Study [published online ahead of print, 2020 Jun 8]. Inflamm Bowel Dis. 2020
11. Romanini L, Passamonti M, Navarria M, et al. Quantitative analysis of contrast- enhanced ultrasonography of the bowel wall can predictdisease activity in inflammatory bowel disease. Eur J Radiol 2014;83 (8):1317–23.
12. Ripollés T, Martínez-Pérez MJ, Paredes JM, et al. The Role of Intravenous Contrast Agent in the Sonographic Assessment of Crohn’s Disease Activity: Is Contrast Agent Injection Necessary? Journal of Crohn's and Colitis 2019; 13: 585-592. doi: 10.1093/ecco-jcc/jjy204.
13. Ma X, Li Y, Jia H, et al. Contrast-enhanced ultrasound in the diagnosis of patients suspected of having active Crohn’s disease: meta- analysis. Ultrasound Med Biol 2015;41(3):659–68.
14. Serafin Z, Bialecki M, Bialecka A, et al. Contrast- enhanced ultrasound for detection of Crohn’s disease activity: systematic review and meta-analysis. J Crohns Colitis 2016;10 (3):354–62.
15. Martinez MJ, Ripolles T, Paredes JM, et al. Intravenous Contrast-Enhanced Ultrasound for Assessing and Grading Postoperative Recurrence of Crohn's Disease. Dig Dis Sci 2019;64(6):1640-50.
16. Paredes JM, Ripolles T, Cortes X, et al. Contrast-enhanced ultrasonography: usefulness in the assessment of postoperative recurrence of Crohn's disease. J Crohns Colitis 2013;7(3):192-201
17. Ripolles T, Martinez-Perez MJ, Paredes JM, et al. Contrast-enhanced ultrasound in the differentiation between phlegmon and abscess in Crohn's disease and other abdominal conditions. Eur J Radiol. 2013;82(10):e525-31.
18. Nylund K, Jirik R, Mezl M, et al. Quantitative contrast-enhanced ultrasound comparison between inflammatory and fibrotic lesions in patients with Crohn's disease. Ultrasound Med Biol 2013;39(7):1197-206.
19. Vestito A, Marasco G, Maconi G, et al. Role of Ultrasound Elastography in the Detection of Fibrotic Bowel Strictures in Patients with Crohn's Disease: Systematic Review and Meta-Analysis. Ultraschall Med. 2019;40(5):646-54.
20. Kucharzik T, Wittig BM, Helwig U, et al. Use of Intestinal Ultrasound to Monitor Crohn's Disease Activity. Clin Gastroenterol Hepatol 2017;15(4):535-42.
21. Quaia E, Sozzi M, Angileri R, et al. Time intensity curves obtained after microbubble injection can be used to differentiate responders from non responders among patients with clinically active Crohn disease after 6 weeks of pharmacologic treatment. Radiology 2016;281(2):606–16.
22. Socaciu M, Ciobanu L, Diaconu B, et al. Non-invasive assessment of inflammation and treatment response in patients with Crohn’s disease and ulcerative colitis using contrast-enhanced ultrasonography quantification. J Gastrointestin Liver Dis 2015;24(4):457–65.
23. Ripollés T, Paredes JM, Martínez-Pérez MJ, et al. Ultrasonographic changes at 12 weeks of anti-TNF drugs predict 1-year sonographic response and clinical outcome in Crohn’s disease: a multicenter study. Inflamm Bowel Dis 2016;22(10):2465–73.
24. Smith RL, Taylor KM, Friedman AB, et al. Systematic Review: Clinical Utility of Gastrointestinal Ultrasound in the Diagnosis, Assessment and Management of Patients With Ulcerative Colitis. J Crohns Colitis 2020;14(4):465-479.
25. Girlich C, Schacherer D, Jung EM, et al. Comparison between quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and results of histopathological scoring in ulcerative colitis. Int J Colorectal Dis 2012;2(2):193–8.